nefrНефрологияNephrology (Saint-Petersburg)1561-62742541-9439Pavlov First Saint-Petersburg State Medical University10.24884/1561-6274-2017-3-92-111nefr-270Research ArticleПРОГРАММА НЕПРЕРЫВНОГО ПОСЛЕДИПЛОМНОГО ОБРАЗОВАНИЯ ПО НЕФРОЛОГИИPROGRAM ON CONTINUOUS POSTGRADUATE EDUCATION ON NEPHROLOGYЛЕЧЕНИЕ ПАЦИЕНТОВ С ХРОНИЧЕСКОЙ БОЛЕЗНЬЮ ПОЧЕК 5 СТАДИИ (ХБП 5) МЕТОДАМИ ГЕМОДИАЛИЗА И ГЕМОДИАФИЛЬТРАЦИИ. КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИTREATMENT OF PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 5 (CKD 5) BY HEMODIALYSIS AND HEMODIAFILTRATION. CLINICAL GUIDELINESСтроковА. Г.StrokovG. A.ГуревичК. Я.GurevichK. Ya.ИльинА. П.IlyinA. P.ДенисовА. Ю.DenisovA. Yu.ЗемченковА. Ю.ZemchenkovA. Yu.

доц., к.м.н., отделение диализа, заведующий,

191104, Санкт-Петербург, Литейный пр., д. 56

Associate prof., MD, Phd, department of dialysis, chair,

191104, Saint-Petersburg Liteiny pr, 56

kletk@inbox.ruАндрусевА. М.AndrusovA. M.ШутовЕ. В.ShutovE. V.КотенкоО. Н.KotenkoO. N.ЗлоказовВ. Б.ZlokazovV. B.Городская Мариинская больницаРоссияCity Mariinsky hospitalRussian Federation20172504201721392111Copyright © Строков А.Г., Гуревич К.Я., Ильин А.П., Денисов А.Ю., Земченков А.Ю., Андрусев А.М., Шутов Е.В., Котенко О.Н., Злоказов В.Б., 20172017Строков А.Г., Гуревич К.Я., Ильин А.П., Денисов А.Ю., Земченков А.Ю., Андрусев А.М., Шутов Е.В., Котенко О.Н., Злоказов В.Б.Strokov G.A., Gurevich K.Y., Ilyin A.P., Denisov A.Y., Zemchenkov A.Y., Andrusov A.M., Shutov E.V., Kotenko O.N., Zlokazov V.B.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nephrolog.ru/jour/article/view/270

.

.

ReferencesБикбов БТ, Томилина Н.А. Заместительная терапия больных с хронической почечной недостаточностью в Российской Федерации в 1998–2011 гг. (Отчет по данным Российского регистра заместительной почечной терапии). Нефрология и диализ 2014; 16 (1)Бикбов БТ, Томилина Н.А. Заместительная терапия больных с хронической почечной недостаточностью в Российской Федерации в 1998–2011 гг. (Отчет по данным Российского регистра заместительной почечной терапии). Нефрология и диализ 2014; 16 (1)Готье СВ, Мойсюк ЯГ, Хомяков СМ. Донорство и трансплантация органов в Российской Федерации. VI сообщение регистра Российского трансплантологического общества. Вестник трансплантологии и искусственных органов 2014; 16 (2)Готье СВ, Мойсюк ЯГ, Хомяков СМ. Донорство и трансплантация органов в Российской Федерации. VI сообщение регистра Российского трансплантологического общества. Вестник трансплантологии и искусственных органов 2014; 16 (2)Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150: 604–612Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150: 604–612KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2013; 3 (1)KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2013; 3 (1)European Best Practice Guidelines for Haemodialysis (Part 1) Nephrol Dial Transplant (2002) 17 [Suppl 7]European Best Practice Guidelines for Haemodialysis (Part 1) Nephrol Dial Transplant (2002) 17 [Suppl 7]European best practice guidelines on haemodialysis (Part 2) Nephrol Dial Transplant (2007) 22 [Suppl 2]:European best practice guidelines on haemodialysis (Part 2) Nephrol Dial Transplant (2007) 22 [Suppl 2]:National Kidney Foundation KDOQI Clinical Practice Guidelines for Hemodialysis Adequacy, Update 2006National Kidney Foundation KDOQI Clinical Practice Guidelines for Hemodialysis Adequacy, Update 2006National Kidney Foundation KDOQI Clinical Practice Guidelines for Vascular Access, Update 2006National Kidney Foundation KDOQI Clinical Practice Guidelines for Vascular Access, Update 2006Locatelli F, Martin-Malo A, Hannedouche T et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 2009;20(3):645-654Locatelli F, Martin-Malo A, Hannedouche T et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 2009;20(3):645-654Grooteman MP, van den Dorpel MA, Bots ML et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 2012;23(6):1087-1096Grooteman MP, van den Dorpel MA, Bots ML et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 2012;23(6):1087-1096Ok E, Asci G, Toz H et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with highflux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant 2013;28(1):192-202Ok E, Asci G, Toz H et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with highflux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant 2013;28(1):192-202Maduell F, Moreso F, Pons M et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 2013;24(3):487-497Maduell F, Moreso F, Pons M et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 2013;24(3):487-497Tattersall J et EUDIAL, Online haemodiafiltration: definition, dose quantification and safety revisited. Nephrol Dial Transplant 2013 ;28(3):542-550Tattersall J et EUDIAL, Online haemodiafiltration: definition, dose quantification and safety revisited. Nephrol Dial Transplant 2013 ;28(3):542-550Davenport A. Optimization of heparin anticoagulation for hemodialysis. Hemodial Int 2011;15 (suppl 1):43-48Davenport A. Optimization of heparin anticoagulation for hemodialysis. Hemodial Int 2011;15 (suppl 1):43-48Fischer KG. Essentials of anticoagulation in hemodialysis. Hemodial Int 2007;11:178-189Fischer KG. Essentials of anticoagulation in hemodialysis. Hemodial Int 2007;11:178-189Wizemann V, Wabel P, Chamney P et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 2009; 24(5):1574-1579Wizemann V, Wabel P, Chamney P et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 2009; 24(5):1574-1579E.Movilli, P.Gaggia, R.Zubani et al. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. Nephrol Dial Transplant 2007; 22: 3547–3552E.Movilli, P.Gaggia, R.Zubani et al. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. Nephrol Dial Transplant 2007; 22: 3547–3552Dialysate for hemodialysis ANSI/AAMI RD52:2004Dialysate for hemodialysis ANSI/AAMI RD52:2004Смирнов АВ, Нестерова ОБ, Суглобова ЕД и др. Клинико-лабораторная оценка эффективности лечения больных с терминальной стадией почечной недостаточности с использованием хронического гемодиализа и ацидосукцината. Тер Арх 2013; 85 (1): 69-75Смирнов АВ, Нестерова ОБ, Суглобова ЕД и др. Клинико-лабораторная оценка эффективности лечения больных с терминальной стадией почечной недостаточности с использованием хронического гемодиализа и ацидосукцината. Тер Арх 2013; 85 (1): 69-75Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993;4(5):1205-1213Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993;4(5):1205-1213Daugirdas JT. Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn. Adv Ren Replace Ther 1995;2(4):295-304Daugirdas JT. Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn. Adv Ren Replace Ther 1995;2(4):295-304Gotch FA. Evolution of the single-pool urea kinetic model. Semin Dial 2001;14(4):252-256Gotch FA. Evolution of the single-pool urea kinetic model. Semin Dial 2001;14(4):252-256National Kidney Foundation KDOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients 2005National Kidney Foundation KDOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients 2005European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure Nephrol Dial Transplant 1999;14 [Suppl 5]European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure Nephrol Dial Transplant 1999;14 [Suppl 5]Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure Nephrol Dial Transplant 2004;19 [Suppl 2]Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure Nephrol Dial Transplant 2004;19 [Suppl 2]National Kidney Foundation KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin TargetNational Kidney Foundation KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin TargetKDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease Kidney Int Supplements 2012; Vol 2, Issue 4, August (2)KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease Kidney Int Supplements 2012; Vol 2, Issue 4, August (2)National Kidney Foundation KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease 2003National Kidney Foundation KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease 2003KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD–MBD). Kidney Int 2009; Vol 76, Suppl 113KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD–MBD). Kidney Int 2009; Vol 76, Suppl 113National Kidney Foundation KDOQI Nutrition Guidelines American Journal of Kidney Diseases,Vol 35, No 6, Suppl 2, 2000: S1-S3National Kidney Foundation KDOQI Nutrition Guidelines American Journal of Kidney Diseases,Vol 35, No 6, Suppl 2, 2000: S1-S3National Kidney Foundation KDOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients 2005National Kidney Foundation KDOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients 2005Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-383Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-383Floege J, Kim J, Ireland E et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 2011; 26:1948–1955Floege J, Kim J, Ireland E et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 2011; 26:1948–1955Zimmermann J, Herrlinger S, Pruy A et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55(2):648-658Zimmermann J, Herrlinger S, Pruy A et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55(2):648-658Robinson BM, Tong L, Zhang J et al. Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2012;82(5):570-580Robinson BM, Tong L, Zhang J et al. Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2012;82(5):570-580

The authors declare that there are no conflicts of interest present.